Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

• Status: Completed
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasing overall eyelash prominence in self-identified African American/ethnic black subjects exhibiting hypotrichosis of the eyelashes (inadequate or not enough eyelashes).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• African American/ethnic black

• Adults at least 18 years of age

• Eyelash prominence assessment of minimal or moderate

Exclusion Criteria:

• Subjects with uneven lashes or longer on one side than the other

• Any eye disease or abnormality

• Eye surgery

• Severe hyperpigmentation around the eye

• Eyelash implants

• Eyelash extension application

• Any use of eyelash growth products within 6 months

• Any use of prescription eyelash growth products

• Treatments that may affect hair growth

• Requiring eye drop medications for glaucoma